Speakers

Jason Acker

Professor

University of Alberta, Canada

Joseph Carosi

Associate Director

Novartis, USA

Veeren Chauhan

Research Fellow

University of Nottingham, USA

Francesco Cicirello

Inspector

Australian Government Department of Health, Australia

Jakub Cierny

Senior Quality Compliance Manager

Sotio AS, Czech Republic

David Dobnik

Scientific Associate

National Institute of Biology, Slovenia

Miguel Esteves

Associate Professor, Horae Gene Therapy Center

University of Massachusetts Medical School , USA

Miguel Forte

CEO

Zelluna Immunotherapy, Norway

Guanping Gao

Professor, Microbiology & Physiological Systems, Penelope Booth Rockwell Professor in Biomedical Research, Co-Director, Li Weibo Institute for Rare Diseases Research, Director, Horae Gene Therapy Center and Vector Core, Scientific Director

UMMS-China Program Office, USA

Chris Gemmiti, Ph.D.

Head of Operations

Sentien Biotechnologies Inc.

Dan Gincel

VP University Partnerships, TEDCO Executive Director, MD Stem Cell Research Fund

Maryland Stem Cell Research Fund, USA

Patrick Hanley

Immunotherapy GMP & Research Assistant Professor & Director

Children's National Health System, USA

John Heffernan

V.P. Commercial Manufacturing

Astellas

Timothy Herpin

Chief Business Officer

Caribou Biosciences

John Hewes

Senior Specialist

Invention Development, DHHS/NIH/NCI Technology Transfer Center, USA

Geoffrey Hodge

Chief Technical Officer

Unum Therapeutics

Meridith Hyres

Senior Specialist, Clinical Supply Management

Biogen, USA

Jian Irish

Global Head of Manufacturing

Kite Pharma, USA

Zeke Johnston

Senior Manager

Editas Medicine, USA

Ohad Karnieli, Ph.D., MBA

CEO

Atvio Biotech

Michael Klichinsky

Co-Founder

Carisma Therapeutics

Marcos Langtry

Outsourced Manufacturing and Development Director

TiGenix, Belgium

Michael Leek

Chief Executive

TC BioPharm

Graham Lilley

Process Development Engineer

Caribou Biosciences, Inc., USA

Ginette Michaud

Director, Office of Biological Products Operations

FDA, USA

Amanda Micklus

Principal Analyst

Datamonitor Healthcare

Jeffrey Miller

Professor of Medicine, Deputy Director, Masonic Cancer Center, Division of Hematology, Oncology and Transplantation, University of Minnesota

Roger L. and Lynn C. Headrick Family Chair in Cancer Therapeutics, USA

Ali Mohamed

VP, CMC

Immatics, USA

Shashi Murthy, PhD

Professor of Chemical Engineering & Sherman Center Director

Northeastern University

Knut Niss

Chief Technology Officer

Mustang Bio, USA

Bilal Omer

Assistant Professor

Baylor College of Medicine, USA

Felicia Pagliuca

VP Cell Biology R&D

Semma Therapeutics, USA

Chad Presher

Associate Director, Clinical Drug Supply

Biogen, USA

Gabriele Proetzl

Director, Regenerative Medicine

Takeda, USA (pending final confirmation)

Lior Raviv

Vice President

Pluristem Therapeutics Inc.

Franz Schnetzinger

Director Analytical Development

Gyroscrope, UK

Angela Scott

Founder & Chief Operating Officer at TC Biopharm, UK

TC Biopharm, UK

David Smith

Chief Commercial Officer

Healios

Devyn Smith

Chief Strategy Officer and Head of Operations

Sigilon Therapeutics, USA

Austin Thiel

Senior Principal Scientist

Semma Therapeutics, USA

Nick Timmins, PhD

Vice President, Process Science

Bluerock Therapeutics

Wouter Van t’Hof

Cord Blood Bank Director

Cleveland Cord Blood Centre, USA

Loic Vincent

Head Oncology & Immunology Research Partnerships, Head of Cell Therapy Discovery

Takeda, USA

Xiuyan Wang

Assistant Director

Memorial Sloan Kettering Cancer Center, USA

Dan Wilkinson

Computational Biologist

BlueRock Therapeutics, USA

Erik Woods

Co-Founder and Chief Science Officer

Ossium Health, Inc., USA